Sign in
4

Changes in Ownership

Starling Oncology, Inc. Filed Acc 0001213900-25-084700

Director sold 6,700,000 shares at $3.09 ($20,703,000)

From the SEC's structured data for this filing

Trades in this filing

M33 Growth I L.P. · Director

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2025-09-04 Sale : show line 1 in the form −6,018,168 $3.09 $18,596,139 7,932,389 D
2025-09-04 Sale : show line 2 in the form −681,832 $3.09 $2,106,861 590,892 I
Open-market sales · 6,700,000 sh · avg $3.09 · $20,703,000
Loading xslF345X05/ownership.xml…